NFKB1 and neoplasm: CA synergistically interacts with berberine to elicit a chemo-preventive role by shutting down tumor bioenergetics by upregulating AMP-dependent protein kinase (AMPK) and mTOR pathways while inhibiting the NF-κB signaling axis [175].